Urolyte Injection

Urolyte Injection belongs to a class of drugs called antithrombotic agents used to dissolve harmful blood clots in blood vessels. It is used in conditions such as peripheral vascular thromboembolism (blood clot in a large vein), cerebral thrombosis (blood clot in venous sinuses of the brain), cerebral infarction (stroke), myocardial infarction (heart attack),  and pulmonary embolism (blood clots in the lungs).

Urolyte Injection contains urokinase that works by converting plasminogen to the enzyme plasmin. Plasmin degrades fibrin clots as well as fibrinogen and some other plasma proteins. It effectively dissolves the blood clots, restoring the blood flow to the affected area.

Urolyte Injection will be administered by a healthcare professional. In some cases, Urolyte Injection may cause unusual bleeding, nausea, vomiting, and loss of appetite. Most of these side effects do not necessitate medical treatment and fade away with time. Please visit your doctor if the side effects persist or worsen.

If you are pregnant or breastfeeding, inform your doctor before taking Urolyte Injection. Keep your doctor updated on your medical condition and medications to rule out any potential interactions. Avoid consuming alcohol along with Urolyte Injection as it could increase the risk of bleeding. Urolyte Injection should not be given to children because its safety and effectiveness have not been proven.

Urolyte Injection belongs to a class of drugs known as antithrombotic medications. Urolyte Injection contains urokinase. It works by dissolving or lysing the harmful or unwanted blood clots in the blood vessels. Thus it restores the blood flow to the affected blood vessels, preventing various illnesses caused by blood clots. It is used in conditions such as peripheral vascular thromboembolism (blood clot in a large vein), cerebral thrombosis (blood clot in venous sinuses of the brain), cerebral infarction (stroke), myocardial infarction (heart attack),  and pulmonary embolism (blood clots in the lungs).

Before taking Urolyte Injection, tell your doctor if you are pregnant or breastfeeding. Urolyte Injection should be used with caution in elderly people because they are at significant risk of bleeding. If you have active tuberculosis, stomach ulcers, severe uncontrolled arterial hypertension, bleeding abnormalities, severe hepatic or renal diseases, inform your doctor before taking Urolyte Injection. Also, let your doctor know if you have had a recent cerebrovascular accident, as well as intracranial or intraspinal surgery. Inform your doctor that you take Urolyte Injection if are due to undergo surgery. You should avoid alcohol because it increases the risk of bleeding. Urolyte Injection is not recommended for children since its safety and effectiveness have not been proven.